Company page

Aridis Pharmaceuticals Inc.

Aridis Pharmaceuticals Inc. (Ticker: ARDS) is a public company based in the United States, focusing on the development of innovative therapies for infectious diseases. With a market capitalization of approximately $8.91 billion, the company is actively engaged in advancing its pipeline of pharmaceutical products. Aridis aims to address unmet medical needs through its research and development efforts in the biopharmaceutical sector.